Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 02 Jan 2026 for Janux Therapeutics, Inc., €29k. Read the official filing
Filing timeline
BuySaleThomas DiRaimondo
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Thomas DiRaimondo: trading record in brief
Thomas DiRaimondo, listed as senior executive, appears in our data through filings on Janux Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 3 filings, for trades running from 27 September 2024 to 2 January 2026.
Sales make up the whole of the open-market record (2 sales, €208k). The rest of the record consists of 1 share grant. In 2026 alone, the filings show no purchases and 1 sale.
The latest filing, published on 2 January 2026, reports an open-market sale of €29k in Janux Therapeutics, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas DiRaimondo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
2,505 shares@ US$13.730.0035% mcap50.0% of flowCommon StockSEC:0002005618-26-000002:0
24,000 shares0Common StockSEC:0001415889-25-000673:0
4,325 shares@ US$46.205775.3% of flowCommon StockSEC:0001415889-24-024076:0
3 of 3 declarations
